Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 2 2Phase EARLY_PHASE1 1

Status

Recruiting 3Completed 3Withdrawn 2Unknown 2Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Hemangioma 2

Interventions

Cyclophosphamide 166Docetaxel 154Bevacizumab 153Carboplatin 148Gemcitabine 146Cisplatin 146pembrolizumab 142Radiotherapy 135Paclitaxel 132Capecitabine 122Rituximab 115Oxaliplatin 104Fluorouracil 103Nivolumab 94Irinotecan 85Doxorubicin 85Pemetrexed 83Leucovorin 82Dexamethasone 82fludarabine 74fludarabine phosphate 72Bortezomib 69Etoposide 67Erlotinib Hydrochloride 66Cetuximab 65Methotrexate 58Trastuzumab 56Cytarabine 54Lenalidomide 50Everolimus 49

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Terminated × Solutions × Clear all
NCT01074437 2018-10-04

Corticosteroids With Placebo Versus Corticosteroids With Propranolol Treatment of Infantile Hemangiomas (IH)

Seattle Children's Hospital

Phase 2 Terminated
9 enrolled 5 charts

Hemangioma

NCT00555464 2013-06-11

Clinical Trial of Vincristine vs. Prednisolone for Treatment of Complicated Hemangiomas

Medical College of Wisconsin

Phase 2 Terminated
8 enrolled 7 charts

Hemangioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡